HomeYB3 • FRA
add
Shin Nippon Biomedical Laboratories Ltd
Previous close
€8.75
Day range
€8.45 - €8.45
Year range
€8.45 - €17.10
Market cap
59.24B JPY
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 6.10B | 1.28% |
Operating expense | 3.00B | 69.28% |
Net income | 828.00M | 1,317.65% |
Net profit margin | 13.57 | 1,300.88% |
Earnings per share | — | — |
EBITDA | 586.00M | -66.80% |
Effective tax rate | 26.00% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.00B | 43.86% |
Total assets | 71.37B | 21.62% |
Total liabilities | 41.12B | 35.50% |
Total equity | 30.25B | — |
Shares outstanding | 41.63M | — |
Price to book | 0.01 | — |
Return on assets | 0.66% | — |
Return on capital | 0.84% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 828.00M | 1,317.65% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1957
Website
Employees
1,344
